Literature DB >> 33788251

Variation in propofol induction doses administered to surgical patients over age 65.

Robert B Schonberger1, Amit Bardia1, Feng Dai2, George Michel1, David Yanez2, Jeptha P Curtis3, Michelle T Vaughn4, Matthew M Burg1,3, Michael Mathis4, Sachin Kheterpal4, Shamsuddin Akhtar1, Nirav Shah4.   

Abstract

BACKGROUND/
OBJECTIVES: Advanced age is associated with increased susceptibility to acute adverse effects of propofol. The present study aimed to describe patterns of propofol dosing for induction of general anesthesia before endotracheal intubation in a nationwide sample of older adults presenting for surgery.
DESIGN: Retrospective observational study using the Multicenter Perioperative Outcomes Group data set.
SETTING: Thirty-six institutions across the United States. PARTICIPANTS: A total of 350,766 patients aged over 65 years who received propofol for general anesthetic induction and endotracheal intubation between 2014 and 2018. INTERVENTION: None. MEASUREMENTS: Total induction bolus dose of propofol administered.
RESULTS: The mean (SD) weight-adjusted propofol dose was 1.7 (0.6) mg/kg. The mean prevalent propofol induction dose exceeded the upper bound of what has been described as the typical geriatric dose requirement across every age category examined. The percent of patients receiving propofol induction doses above the described typical geriatric range was 64.8% (95% CI 64.6-65.0), varying from 73.8% among patients aged 65-69 to 45.8% among patients aged 80 and older.
CONCLUSION: The present study of a large multicenter cohort demonstrates that prevalent propofol dosing commonly falls above the published typically required dose range for patients aged ≥65 in nationwide anesthetic practice. Widespread variability in induction dose administration remains incompletely explained by known patient variables. The nature and clinical consequences of these unexplained dosing decisions remain important topics for further study. Observed discordance between expected and actual induction dosing raises the question of whether there should be reconsideration of widespread provider practice or, alternatively, whether what is published as the typical propofol induction dose range should be revisited.
© 2021 The American Geriatrics Society.

Entities:  

Keywords:  anesthetic induction; geriatric dosing; propofol

Mesh:

Substances:

Year:  2021        PMID: 33788251      PMCID: PMC8373684          DOI: 10.1111/jgs.17139

Source DB:  PubMed          Journal:  J Am Geriatr Soc        ISSN: 0002-8614            Impact factor:   7.538


  37 in total

1.  The role of anesthesia in surgical mortality.

Authors:  R D DRIPPS; A LAMONT; J E ECKENHOFF
Journal:  JAMA       Date:  1961-10-21       Impact factor: 56.272

2.  Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions.

Authors:  Andrew S Levey; Lesley A Stevens
Journal:  Am J Kidney Dis       Date:  2010-04       Impact factor: 8.860

3.  A modification of the Elixhauser comorbidity measures into a point system for hospital death using administrative data.

Authors:  Carl van Walraven; Peter C Austin; Alison Jennings; Hude Quan; Alan J Forster
Journal:  Med Care       Date:  2009-06       Impact factor: 2.983

4.  The Association of Frailty With Outcomes and Resource Use After Emergency General Surgery: A Population-Based Cohort Study.

Authors:  Daniel I McIsaac; Husein Moloo; Gregory L Bryson; Carl van Walraven
Journal:  Anesth Analg       Date:  2017-05       Impact factor: 5.108

5.  Time for a New Approach to Studying Older People with Ischemic Heart Disease.

Authors:  John A Dodson; Sarwat I Chaudhry; Harlan M Krumholz
Journal:  J Am Geriatr Soc       Date:  2017-05-11       Impact factor: 5.562

6.  An Analysis of Anesthesia Induction Dosing in Female Older Adults.

Authors:  Eric Y Chen; George Michel; Bin Zhou; Feng Dai; Shamsuddin Akhtar; Robert B Schonberger
Journal:  Drugs Aging       Date:  2020-06       Impact factor: 3.923

7.  Risk of Epidural Hematoma after Neuraxial Techniques in Thrombocytopenic Parturients: A Report from the Multicenter Perioperative Outcomes Group.

Authors:  Linden O Lee; Brian T Bateman; Sachin Kheterpal; Thomas T Klumpner; Michelle Housey; Michael F Aziz; Karen W Hand; Mark MacEachern; Christopher G Goodier; Jeffrey Bernstein; Melissa E Bauer
Journal:  Anesthesiology       Date:  2017-06       Impact factor: 7.892

8.  Sugammadex versus Neostigmine for Reversal of Neuromuscular Blockade and Postoperative Pulmonary Complications (STRONGER): A Multicenter Matched Cohort Analysis.

Authors:  Sachin Kheterpal; Michelle T Vaughn; Timur Z Dubovoy; Nirav J Shah; Lori D Bash; Douglas A Colquhoun; Amy M Shanks; Michael R Mathis; Roy G Soto; Amit Bardia; Karsten Bartels; Patrick J McCormick; Robert B Schonberger; Leif Saager
Journal:  Anesthesiology       Date:  2020-06       Impact factor: 7.892

Review 9.  Frailty syndrome: an overview.

Authors:  Xujiao Chen; Genxiang Mao; Sean X Leng
Journal:  Clin Interv Aging       Date:  2014-03-19       Impact factor: 4.458

Review 10.  Frailty and post-operative outcomes in older surgical patients: a systematic review.

Authors:  Hui-Shan Lin; J N Watts; N M Peel; R E Hubbard
Journal:  BMC Geriatr       Date:  2016-08-31       Impact factor: 3.921

View more
  3 in total

1.  Reply to: Comment on: Variation in propofol induction doses administered to surgical patients over 65.

Authors:  Shamsuddin Akhtar; Amit Bardia; Robert B Schonberger
Journal:  J Am Geriatr Soc       Date:  2021-06-29       Impact factor: 7.538

2.  Goldilocks and propofol dosage in older adults: Too much, too little, or just right?

Authors:  Michael J Devinney; Miles Berger
Journal:  J Am Geriatr Soc       Date:  2021-05-08       Impact factor: 7.538

3.  Effective dose of propofol combined with a low-dose esketamine for gastroscopy in elderly patients: A dose finding study using dixon's up-and-down method.

Authors:  Yuling Zheng; Yafei Xu; Bixin Huang; Ying Mai; Yiwen Zhang; Zhongqi Zhang
Journal:  Front Pharmacol       Date:  2022-09-20       Impact factor: 5.988

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.